PDF _ RS21418 - Regulation of Plant-Based Pharmaceuticals
8-Mar-2005; Geoffrey S. Becker; 6 p.

Update: June 3, 2005

Abstract: Among many genetically engineered crops being developed are a number modified to produce pharmaceutical compounds (none yet commercialized). Proponents say such plant-based proteins could be produced more cheaply than by conventional methods and economically benefit farmers. But critics see risks, such as potential environmental, food safety, and trade problems. Among the issues is whether the current system for regulating biotechnology is adequate. This report will be updated if events warrant. [read report]

Topics: Agriculture, General Interest

265 
Start Over